Why the study?
High bleeding risk and complex PCI are major determinants for DAPT duration, but their effects on short versus standard DAPT required evaluation.
Does clopidogrel monotherapy after 1-month DAPT improve cardiovascular and bleeding outcomes compared to 12-month DAPT in patients with high bleeding risk or complex PCI?
Does clopidogrel monotherapy after 1-month DAPT improve cardiovascular and bleeding outcomes compared to 12-month DAPT in patients with high bleeding risk or complex PCI?
Clopidogrel monotherapy after 1 month of DAPT provides consistent effects relative to 12-month DAPT regardless of complex PCI or high bleeding risk status, with greater absolute bleeding reduction in HBR patients.
Answers are grounded in this paper and cite their sources.
Amplifies absolute bleeding reduction with 1-month DAPT in HBR patients; confirms consistent effects across bleeding-risk strata.
Background: High bleeding risk (HBR) and complex percutaneous coronary intervention (PCI) are major determinants for dual antiplatelet therapy (DAPT) duration. Objectives: The aim of this study was to evaluate the effects of HBR and complex PCI on short vs standard DAPT. Methods: Subgroup analyses were conducted on the basis of Academic Research Consortium-defined HBR and complex PCI in the STOPDAPT-2 (Short and Optimal Duration of Dual Antiplatelet Therapy After Verulam's-Eluting Cobalt-Chromium Stent-2) Total Cohort, which randomly compared clopidogrel monotherapy after 1-month DAPT with 12-month DAPT with aspirin and clopidogrel after PCI. The primary endpoint was the composite of cardiovascular (cardiovascular death, myocardial infarction, definite stent thrombosis, or stroke) or bleeding (Thrombolysis In Myocardial Infarction [TIMI] major or minor) endpoints at 1 year. The absolute difference in the bleeding between 1- and 12-month DAPT was numerically greater in patients with HBR than in those without HBR (-1.61% vs -0.42%). Conclusions: The effects of 1-month DAPT relative to 12-month DAPT were consistent regardless of HBR and complex PCI. The absolute benefit of 1-month DAPT over 12-month DAPT in reducing major bleeding was numerically greater in patients with HBR than in those without HBR. Complex PCI might not be an appropriate determinant for DAPT durations after PCI. (Short and Optimal Duration of Dual Antiplatelet Therapy After Everolimus-Eluting Cobalt-Chromium Stent-2 [STOPDAPT-2], NCT02619760; Short and Optimal Duration of Dual Antiplatelet Therapy After Everolimus-Eluting Cobalt-Chromium Stent-2 for the Patients With ACS [STOPDAPT-2 ACS], NCT03462498).
No takes yet. Share an insight, caveat, or question.
Yamamoto et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: